爱尔眼科
(300015)
| 流通市值：995.34亿 | | | 总市值：1170.34亿 |
| 流通股本：79.31亿 | | | 总股本：93.25亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 11,507,127,175.61 | 6,026,140,250.98 | 20,982,894,148.5 | 16,301,500,342.75 |
| 营业收入 | 11,507,127,175.61 | 6,026,140,250.98 | 20,982,894,148.5 | 16,301,500,342.75 |
| 二、营业总成本 | 8,759,834,639.24 | 4,570,692,763.37 | 16,628,942,161.66 | 12,268,216,804.7 |
| 营业成本 | 5,919,491,266.64 | 3,132,566,326.27 | 10,886,548,798.66 | 7,984,744,713.2 |
| 税金及附加 | 25,820,398.98 | 12,070,736.76 | 66,734,642.15 | 44,118,998.03 |
| 销售费用 | 1,052,502,139.07 | 544,284,495.4 | 2,151,670,355.18 | 1,640,037,750.51 |
| 管理费用 | 1,559,060,198.23 | 761,077,771.03 | 2,989,059,100.52 | 2,225,346,478.18 |
| 研发费用 | 154,835,276.41 | 78,772,510.94 | 320,631,154.37 | 233,150,517.78 |
| 财务费用 | 48,125,359.91 | 41,920,922.97 | 214,298,110.78 | 140,818,347 |
| 其中:利息费用 | 136,875,553.88 | 69,514,250.67 | 255,561,402.92 | 184,652,799.88 |
| 其中:利息收入 | 41,144,113.18 | 20,039,529.55 | 96,046,345.49 | 76,032,588.72 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 33,920,943.02 | 3,323,448.53 | 334,397,998.78 | 214,300,608.2 |
| 加:投资收益 | 7,363,206.85 | 27,992.53 | 213,220,184.07 | 148,922,310.66 |
| 资产处置收益 | 5,768,314.21 | 596,021.35 | 4,268,866.2 | 3,959,688.25 |
| 资产减值损失(新) | -659,244.46 | - | -187,757,063.3 | -560,450.44 |
| 信用减值损失(新) | -85,482,484.23 | -36,464,658.4 | -112,108,903.15 | -58,350,296.17 |
| 其他收益 | 21,347,861.37 | 12,699,468.05 | 218,944,390.36 | 102,272,589.9 |
| 四、营业利润 | 2,729,551,133.13 | 1,435,629,759.67 | 4,824,917,459.8 | 4,443,827,988.45 |
| 加:营业外收入 | 3,579,450.19 | 1,686,462.8 | 22,024,632.78 | 9,976,995.69 |
| 减:营业外支出 | 70,144,385.01 | 33,196,201.89 | 252,659,826.68 | 105,977,189.17 |
| 五、利润总额 | 2,662,986,198.31 | 1,404,120,020.58 | 4,594,282,265.9 | 4,347,827,794.97 |
| 减:所得税费用 | 443,315,683.98 | 237,601,059.51 | 858,152,583.94 | 679,621,278.09 |
| 六、净利润 | 2,219,670,514.33 | 1,166,518,961.07 | 3,736,129,681.96 | 3,668,206,516.88 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 2,219,670,514.33 | 1,166,518,961.07 | 3,736,129,681.96 | 3,668,206,516.88 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 2,050,956,595.32 | 1,049,755,960.4 | 3,556,055,831.7 | 3,451,768,879.59 |
| 少数股东损益 | 168,713,919.01 | 116,763,000.67 | 180,073,850.26 | 216,437,637.29 |
| 扣除非经常损益后的净利润 | 2,039,905,663.09 | 1,060,021,212.23 | 3,098,546,707.48 | 3,113,078,191.65 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.22 | 0.11 | 0.38 | 0.37 |
| (二)稀释每股收益 | 0.22 | 0.11 | 0.38 | 0.37 |
| 八、其他综合收益 | 216,116,289.04 | 61,714,095.38 | -91,049,313.04 | -3,449,938.8 |
| 归属于母公司股东的其他综合收益 | 217,626,901.95 | 62,591,565.22 | -74,759,095.49 | -10,855,829.74 |
| 九、综合收益总额 | 2,435,786,803.37 | 1,228,233,056.45 | 3,645,080,368.92 | 3,664,756,578.08 |
| 归属于母公司股东的综合收益总额 | 2,268,583,497.27 | 1,112,347,525.62 | 3,481,296,736.21 | 3,440,913,049.85 |
| 归属于少数股东的综合收益总额 | 167,203,306.1 | 115,885,530.83 | 163,783,632.71 | 223,843,528.23 |
| 公告日期 | 2025-08-27 | 2025-04-25 | 2025-04-25 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |